2 studies found for:    16198768 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Peg-interferon
2 Unknown  High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
Condition: Melanoma (Skin)
Intervention: Biological: recombinant interferon alfa

Indicates status has not been verified in more than two years